The Value of Morphometry and DNA Flow Cytometry in Addition to Classic Prognosticators in Superficial Urinary Bladder Carcinoma

Size: px
Start display at page:

Download "The Value of Morphometry and DNA Flow Cytometry in Addition to Classic Prognosticators in Superficial Urinary Bladder Carcinoma"

Transcription

1 The Value of Morphometry and DNA Flow Cytometry in Addition to Classic Prognosticators in Superficial Urinary Bladder Carcinoma EDWARD C. M. BLOMJOUS, M.D., NELLIE W. SCHIPPER, M.Sc, JAN P. A. BAAK, M.D., PH.D., WINAND VOS, M.D., HERMAN J DE VOOGT, M.D., PH.D., AND CHRIS J. L. M. MEIJER, M.D., PH.D. In 8 patients with primary superficial bladder carcinoma Tumor Nodes Metastasis (TNM classification: stages Ta and Tl) with adequate follow-up of at least four years, the value of selective nuclear morphometry and DNA flow cytometry on paraffinembedded material in addition to classic prognosticators was assessed. Only the quantitative techniques appeared to be valuable predictors of new tumor occurrence. The recurrence rate in patients with large nuclei (mean nuclear area > 95 iim 2 ; n - 29) and in aneuploid cases (n = 3) was significantly higher (Wilcoxon: P =.5 and P -.1) than in those with small nuclei (mean nuclear area < = 95 Mm 2 ; n = 51) and diploid cases (n = 5). The prevalence of large nuclei and aneuploidy also appeared useful to predict progressive recurrence, i.e., grade 3 or/ and muscle invasive carcinoma (TNM classification: stages T2- T4) (chi-square: P <.1). Clinical follow-up showed that only 62.1% of the cases with large nuclei remained free of progressive recurrence, compared with 92.2% of those with small nuclei (Mantel-Cox: P <.1). For the aneuploid and diploid cases, these figures came to 53.3% and 98% (Mantel-Cox: P <.1). By multivariate analysis DNA ploidy was selected as the best discriminator. None of the classic prognosticators, including histologic grade, had additional prognostic value. Also, morphometry did not add to the prognosis prediction, which can be explained by the considerable overlapping between the prevalence of large nuclei and aneuploidy (24 of 29 and 3 cases, respectively). These findings practically suggest that patients presenting with superficial carcinoma with large nuclei (mean nuclear area > 95 nm 2 ) or aneuploid DNA values should be treated more aggressively. (Key words: Superficial bladder carcinoma; Morphometry; Flow cytometry) Am J Clin Pathol 1989;91: PREDICTION of the clinical behavior of superficial bladder carcinoma (stages Ta and Tl) in a given patient is a major problem in urologic practice. Despite transurethral resection, in a considerable proportion of the patients with superficial carcinoma recurrence develops (actually new occurrence) and 15-25% of cases ultimately progress to high-grade carcinoma (World Health Organization [WHO] classification: grade 3) and muscle invasive disease Tumor Nodes Metastasis (TNM-classification: stages T2-T4). 2,18,2,21 Identification of these patients at an early stage would enable a more appropriate treatment. Received May 9, 1988; received revised manuscript and accepted for publication July 13, Address reprint requests to Dr. Blomjous: Department of Pathology, Free University Hospital, De Boelelaan 1117, 17 MB Amsterdam, The Netherlands. Departments of Pathology and Urology, Free University Hospital, The Netherlands Prognosis partly depends on mucosal field alterations adjacent to the tumor (severe dysplasia or carcinoma in situ). las - 26 In addition, it is believed that prognostic information about progressive recurrence to some extent can be obtained by conventional clinicopathologic features of the initial tumor, such as tumor size, multiplicity, necrosis, histologic grade, and invasion of the lamina propria. 1 ' 318,2 However, these features do not impact heavily on prognosis. More refined techniques therefore have been used for the investigation of primary bladder carcinoma, in order to identify the patients with predilection to progression. These include identification of the pattern of immunohistochemical markers such as cell surface ABO(H) blood group antigen, T-antigen and carcinoembryonic antigen, chromosome analysis, DNA cytophotometry, and ultrastructural determination of alterations of the cell membrane. 9 " Although helpful to some degree, so far none of them appeared useful for routine practice by poor reproducibility or requirement of too sophisticated techniques. 29 Over the last few years nuclear morphometry has supplied an objective and practicable method for the examination of bladder carcinoma, 17,23 and especially the measurement of the areas of selectively sampled large and atypical nuclei has shown prognostic relevance. 5,6 As another objective technique, flow cytometry provides a fast and reliable method to determine the DNA content in large numbers of nuclei. In urology, flow cytometry has shown good correlation of DNA ploidy with tumor grade and stage and patient survival rate. 4,3 However, the value of both techniques as prognostic indicators in superficial bladder carcinoma has yet to be established. In this retrospective study we demonstrate the ability to predict the likelihood of tumor recurrence and progression by selective nuclear morphometry and by DNA flow cytometry on paraffin-embedded tissue of the initial superficial lesion. In addition, the prognostic value of these 243

2 244 BLOMJOUS ET AL. A.J.C.P. March 1989 techniques is shown to be superior to that of classic parameters of tumor behavior, including tumor size, multiplicity, necrosis, histologic grade, and invasiveness. Patients and Materials Materials and Methods Of 158 patients who consecutively presented with primary and untreated superficial transitional cell carcinoma of the urinary bladder (stages Ta and Tl) in our hospital between January 1974 and December 1982, 8 were selected for this study. Patients were included only if the follow-up had lasted at least 48 months, unless they had died of tumor previously. Additional criteria were that formalin-fixed, paraffin-embedded tissue of the initial tumor was still available from the archives and that morphometric andflowcytometric analysis was not impeded by excessive cauterization damage. Eighty cases fulfilled these criteria. Five other cases were excluded because DNA histograms were uninterpretable. Histologic grade was assessed according to the WHO classification 22 by two independent pathologists, in addition to the grading by routine diagnostic procedures. Complete agreement between the three observations occurred for 72% of the cases, and discrepancies did not exceed more than one grade. In case of disagreement, the prevailing grade was assigned. Clinicopathologic stage was assessed according to the TNM classification. 15 Clinical Features Sixty-six patients were male and 14 were female. Age at clinical presentation ranged from 3 to 85 years, and median and mean age were 68 and 67 years, respectively. Of the 8 patients, 5 had initially been treated by transurethral resection only, whereas 27 patients had additional radiotherapy (4, rads) and 3 cytostatic bladder instillation (Adriamycin ) after transurethral resection of the primary tumor. Additional therapy had roughly been based on advanced grade, multiplicity, large size, or ulceration of the tumor, but the regimen was not standardized. Clinical follow-up ranged from 4 to 1 years, mean 7.1 years. Subsequent therapy varied, depending on the number, frequency, and stage of recurrences, general health condition, and likelihood of cure. Morphometry Morphometry was applied on 4-/im-thick hematoxylin and eosin-stained sections. One representative section was selected for each specimen. Analysis was carried out with a projection microscope, equipped with a 1X oil immersion objective, projecting at a graphic tablet (MOP- Videoplan, Kontron, Munich, Federal Republic of Germany) with an optical magnification of 2,X. The nuclear areas of selectively sampled nuclei were measured, according to a previously described morphometric method. 5 This method essentially entails selection of the most atypical area of the histologic slide (size: approximately 5 low-power fields, 1X) and subsequent measurement of ten nuclei that are selected on account of their large size. This method has shown satisfactory intraobserver and interobserver reproducibility (correlation coefficients of mean nuclear area and standard deviation >.9; regression coefficients between.75 and 1.25). Moreover, from a variety of other morphometric procedures, this selective method has emerged as most suitable for discrimination between different tumor grades, resulting in a considerable percentage of 93.2% correctly classified cases from a learning set of bladder tumors. 5 Flow Cytometry Paraffin sections were cut at 5 nm, adjacent to the sections used for morphometry. DNA ploidy was determined with the method described by Hedley and colleagues, 16 with slight modifications. The sections were dewaxed in xylene, rehydrated, and enzymatically dispersed by incubation with protease (Sigma, St. Louis, MO; P- 5255,.5% in.9% buffered saline, ph = 7) for 3 minutes at 37 C, with vigorously intermittent vortex mixing. After mechanical detachment by repeated syringing (21- gauge needles) andfiltrationthrough a 5-/um nylon gauze, the cell suspension was centrifugated, washed in TRIShydrochloride acid buffer, and recentrifugated. The cells werefinallystained with the DNAfluorochrome4',6'-diaminido-2-phenyl-indole dihydrochloride (DAPI, Sigma D-1388), final concentration 2 Mg DAPI/1 ml TRIShydrochloride acid buffer. The cell suspensions were analyzed with the PAS II Flow Cytometer (Partec, Arlesheim, Switzerland), using excitation light at 35 nm. Formalin-fixed mouse thymocytes served as an external standard for instrument setting. The DNA index was determined from the histograms. In agreement with general practice, the first modal cell peak was considered to represent the G/G1 peak of the diploid cell population. Samples were regarded as aneuploid when, in addition to the G/G1 and G2/M peaks, one or more other peaks were detected. Furthermore, samples of which the proportion of peritetraploid cells (DNA indices between 1.9 and 2.1) exceeded 1% of the whole cell population were considered as peritetraploid. Statistical Analysis Significance and clinical relevance of the single classic and quantitative features were analyzed by Wilcoxon's

3 Vol.91 -No. 3 PROGNOSIS IN SUPERFICIAL BLADDER CARCINOMA 245 test and the chi-square test. To study, moreover, their prognostic value in respect to progression, univariate analysis according to Kaplan-Meier was performed. The analysis takes into account the time at risk from transurethral resection of the primary tumor to either progressive recurrence or last follow-up. Differences between the curves were analyzed with the Mantel-Cox test. Multivariate analysis using Cox' regression model was carried out to evaluate the prognostic value of a combination of features. Except from ranking the features to their predictive power, the purpose thereof is to reduce the number of variables because altogether they may contain redundant information. Values ofp<.5 were regarded as significant. Results Distribution of Classic and Quantitative Features and Outcome Fifty-three patients presented with a single primary tumor, 2 patients with two or three tumors, and 7 with more than three primary lesions. The diameter of the tumor or, in case of multiplicity, of the largest lesion, ranged from less than 1 cm to 7 cm: 56 patients had tumors up to 3 cm diameter and 24 carcinomas measured 4 cm or more. Ulceration of the tumor was observed at cystoscopic examination in only four cases. Table 1 shows the distribution of tumor grade and stage resulting from the pathologic assessments. Thirty-one cases were classed as grade 1,41 as grade 2, and 8 as grade 3 carcinoma. Invasive growth was absent in 36 cases (stage Ta); 44 cases showed invasion of the lamina propria (stage Tl). Nuclear morphometry showed mean nuclear areas ranging from 49.7 to fim 2 (mean and standard deviation: and nm 2 ) and standard deviations of 4. to 7.29 nm 2 (mean and standard deviation: 9.92 and 8.2 nm 2 ). Flow cytometry showed 5 tumors to be diploid and 3 aneuploid, of which 14 were peritetraploid and 1 had multiple aneuploid tracings. The coefficient of variation of the diploid peak ranged from 3. to 11.7%, mean 6.5%. Clinical follow-up revealed 59 (74%) patients with one or more recurrences, defined as the number of follow-up cystoscopic studies at which recurrent carcinoma (single or multiple) was noted. Nineteen (24%) patients eventually had progressive recurrence develop at intervals of 3 to 12 months, with median and mean intervals of 24 and 35 months, respectively; progressive recurrence was defined as progression to high-grade (grade 3) carcinoma or to advanced stage (stages T2-T4) of disease. Figure 1 shows the distribution of the mean nuclear area and the DNA index in relation to progressive disease. Table 1. Distribution of Tumor Grade and Stage Grade 1 Stage Ta 23 Stage Tl 8 Total 31 Grade Grade 3 Total DNA l.b Index Features Related to Recurrence None of the classic prognosticators proved to be statistically significant in respect to the prediction of new occurrences. The quantitative parameters, on the other hand, appeared to be valuable predictors. To investigate the value of morphometry, the patients' tumors were divided into a subgroup of tumors with small nuclei (mean nuclear area < = 95 nm 2 ) (n = 51) that showed a relatively low mean recurrence rate (.31 recurrences/month), and a group with large nuclei (mean nuclear area > 95 nm 2 ) (n = 29) with significantly more recurrences (.69 recurrences/month) (Wilcoxon: 3.8; P =.5). Adjustment for therapy effect by omitting from consideration the 3 patients who received additional treatment after resection of the primary tumor resulted in similarfindings,although just not significant anymore for this subgroup (Wilcoxon: 2.92; P =.8). The practical relevance of the feature was limited, however, because analysis by the chi-square statistic did not yield a significant correlation between the presence of large nuclei (mean nuclear area > 95 ^m 2 ) and the occurrence of new carcinomas (chi-square:.21; P =.6 and chi-square:.2; P =.9). Also, DNA ploidy showed prognostic importance, because the recurrence rate was significantly higher for the patient group with aneuploid primary tumors (n = 3) (.87 recurrences/month) than for those with diploid carcinomas (n = 5) (.2 recurrences/month) (Wil O.B.6-.4' o no progression n = 61 progression n = 19 8 i B gblblb e 1 1 * * O H O» 1 o o g o 1 ( 1 1 // 1 Mean Nuclear Area (um21 FIG. 1. Distribution of the mean nuclear area and the DNA index in relation to progressive disease. Horizontally dotted line divides the diploid (n = 5) from the aneuploid (n = 3) tumors. Vertically dotted line divides the tumors with small nuclei (mean nuclear area & 95 fim 2 ) from those with large nuclei (mean nuclear area > 95 fim 2 ). u

4 246 BLOMJOUS ET AL. A.J.C.P. March 1989 coxon: 15.78; P =.1). The clinical relevance of the feature was moreover affirmed by the chi-square statistic because almost all patients with aneuploid tumors (26/ 3) had recurrent disease, whereas one-third of the diploid cases (17/5) remained free of recurrence (chi-square: 4.14; P =.4). Similar results were observed in the group of 5 patients without additional therapy of their primary tumor (Wilcoxon: 7.17; P =.7), although the clinical relevance was not any more obvious for this reduced number of patients (chi-square:.95; P =.3). Features Related to Progressive Recurrence Of the classic features, only advanced tumor grade showed a significant increase of the risk for progression (P =.6). This tendency was not significant for the subset of 5 patients without additional treatment of the primary tumor, which might result from the considerable reduction of especially the grade 3 patient group from eight to four patients. The quantitative techniques appeared valuable in the prediction of progressive recurrent carcinoma (Table 2). The mean and standard deviation of the nuclear area of the progressive cases (n = 19) were both significantly larger than those of the nonprogressive lesions (n = 61) (P =.1 and P -.1), and similar results were obtained for the reduced group of 5 patients without additional therapy (P =.1 and P =.6). The diagnostic value of the mean nuclear area was furthermore indicated by the chi-square statistic, because only 4 of the 51 cases (8%) with small nuclei (mean nuclear area < = 95 jtm 2 ) eventually had progressive recurrence, compared with 15 of the 29 cases (52%) with large nuclei (chi-square: 23.2; P <.1). Also, in the subset of 5 patients without additional treatment, this tendency appeared strongly significant (chi-square: 13.77; P =.2). The importance offlowcytometry was demonstrated by the low incidence of only one patient with progressive recurrence among the 5 diploid cases (2%), against 18 among the 3 aneuploid cases (6%) (chi-square: 34.83; P <.1). The findings were similar in the subset of 5 patients without additional therapy (chi-square: 17.56; P <.1). Univariate and Multivariate Analysis of Progression Figure 1A shows the Kaplan-Meier curves of the cases with relatively small (mean nuclear area < = 95 /*m 2 ; n = 51) and large (mean nuclear area > 95 /um 2 ; n = 29) nuclei: 92.2% and 62.1% respectively, remained free of progressive recurrence during four years follow-up (Mantel-Cox: 19.6; P <.1). Figure IB shows the patients with aneuploid (n = 3) and diploid primary tumors (n = 5): 98% and 53.3%, respectively, were free of progressive recurrence after four years of follow-up (Mantel-Cox: 37.24; P <.1). Adjustment for therapy effect by elimination of 3 patients who had additional therapy did not essentially change these curves (Mantel-Cox: 13.14; P =.3 and Mantel-Cox: 17.91; P <.1). In a stepwise regression analysis, DNA ploidy, being the most important prognosticator, was the first variable entered in the multivariate model. None of the remaining variables contributed significantly to the model. The mean nuclear area is apparently completely explained by the DNA ploidy, and the classic features also have no additional prognostic value. Also, after adjustment for treatment effect, DNA ploidy was the only variable selected in the subset of 5 patients without additional therapy. To evaluate the effect of treatment in addition to transurethral resection, the Kaplan-Meier curves of the patients with and without additional therapy were analyzed: no prognostic difference was observed (Mantel-Cox:.22; P =.9). Moreover, multivariate analysis also showed that additional treatment, when entered as covariate in the model, did not contribute to the prediction of prognosis. Discussion The most significant finding in the current study is that morphometry andflowcytometry both afford a sensitive means to predict whether a patient is at risk to develop new tumor occurrence or, more important, progressive recurrence after resection of primary superficial carcinoma. Quantitative features are shown to be by far superior to the classic prognosticators. In recent years morphometry has proved to be an objective and reproducible method in grading of urinary bladder carcinoma ' 23 In a foregoing comparative study, which was undertaken in view of the different methodologic approaches of morphometry in the literature, the selective method as practiced in the present study emerged as the most suitable method for tumor grading. 5 The procedure of selective sampling explains our two to threefold larger values of the mean nuclear area in comparison with those from the literature, which in general are based on random sampling. 3,1217,23 In another recent study, a close relationship was demonstrated between selective nuclear morphometry and the clinical course in various stages of urinary bladder carcinoma. 6 The present findings additionally show the prognostic usefulness within the category of superficial bladder carcinoma (stage Ta and Tl). To our knowledge, this has not been reported before for any other morphometric approach. Flow cytometric studies have indicated a strong correlation of nuclear DNA content with grade and stage of urinary bladder carcinoma, and many investigators have advocated use of the technique to monitor conservatively treated patients by scanning urine specimens. 78 Moreover, the current findings show that flow cytometry of the primary tumor provides a useful prognostic parameter, as has also been indicated by some previous reports. 4,3 Combinedflowcytometric and cytogenetic analysis has

5 Vol. 91-No. 3 PROGNOSIS IN SUPERFICIAL BLADDER CARCINOMA 247 Table 2. The Mean and Standard Deviation of the Nuclear Area (MNA and SD) of Primary Superficial Bladder Carcinoma in Patients with and Without Progressive Recurrence for the Total Set of Patients and the Subset of Patients Without Additional Therapy MNA (mean ± SD) Statistic SD (mean ± SD) Statistic Total set of patients (n = 8) No progression (n = 61) Progression (n = 19) Subset of patients without additional therapy (n = 5) No progression (n = 38) Progression (n = 12) 85. ± ± ± ±31.42 Wilcoxon: P =.1 Wilcoxon: 1.4 P = ± ± ± rt 6.65 Wilcoxon: 6.33 P=.1 Wilcoxon: 3.47 P =.6 shown that DNA aneuploidy is associated with increased numbers of chromosomes. 31 The simultaneous occurrence of aneuploid DNA values in most of the present cases with large nuclei (mean nuclear area > 95 ^m 2 ) suggests that an increase of the nuclear area also relies at least in part on quantitative chromosomal abnormalities. On the other hand, diploid tumors can still contain qualitative chromosomal abnormalities that remain unrecognized byflowcytometry, 25 ' 31 and the same limitation may apply to morphometry. However, advanced tumor grade and stage are especially associated with gross aneuploidy and higher chromosome counts, 25,31 and a similar tendency is demonstrated for progressive recurrence in the current series of superficial carcinomas. Therefore, the inability of the quantitative techniques to recognize near-diploid and pseudodiploid chromosomal abnormalities does not substantially affect their clinical significance. Despite the considerable overlapping, aneuploid DNA values and large nuclei (mean nuclear area > 95 /im 2 ) do not coincide in each of our cases (Fig. 1). It may be questioned if, in thefivecases with enlarged nuclei and without aneuploidy (Fig. 1; lower, right), the number of cells with abnormal DNA content was large enough to exceed the detection limits of flow cytometry. Another explanation could be that in these cases nuclear enlargement relied on other causes, such as increased nuclear protein content or edema. Nevertheless, nuclear enlargement in these diploid cases was of minor importance because progressive recurrence was not revealed in any of the five patients. The superiority offlowcytometry is shown moreover by the large proportion of progressive recurrences (5%) among the six cases in which morphometry could not detect large nuclei, despite the abnormal DNA values found by flow cytometry (Fig. 1; upper, left). The considerable overlapping between the occurrence of large nuclei (mean nuclear area > 95 nm 2 ) and aneuploid DNA values (24 of 29 and 3 cases, respectively) explains why the combination of both methods does not substantially improve the prognostication as compared with the single techniques. It can be concluded from these findings that application of only one of the techniques would supply sufficient prognostic information, with some preference forflowcytometry. However, morphometry is more thanflowcytometry, a fairly simple and inexpensive technique that can be performed on routinely stained paraffin sections of the primary tumor. The advantage of additional morphometric investigation seems, for the present, that it may serve as an easy check-up for flow cytometric findings or as alternative if the specimen is unsuited for flow cytometry, as, for example, can be by admixture of a large quantity of tissue damaged by cauterization. The clinical implication of the current findings is that patients presenting with an aneuploid superficial primary 9 BO. 7 w. Mantel-Cox: 19.6 p<.1 Mantel-Cox: p<.1 months HNA<-95 um2 (n=51) -- MNA> 95 um2 (n-29) - DNA Index - 1 (n-5) - DNA Index > 1 ln-3) FlG. 2. A (upper). Kaplan-Meier curves of progressive recurrence for patients with small (MNA S 95 jira 2 ) and large (MNA > 95 jtm 2 ) mean nuclear areas of the primary tumor. B (lower). Kaplan-Meier curves of progressive recurrence for patients with diploid and aneuploid primary tumors.

6 248 BLOMJOUS ET AL. A.J.C.P. March 1989 tumor or with relatively large nuclei (mean nuclear area > 95 nm 2 ) should be treated more aggressively. Actually, a minority of 3 patients included in this study received radiotherapy (n = 27) or cytostatic bladder instillation (n = 3) in addition to transurethral resection of their primary tumor. Despite this, their clinical outcome did not appear to be significantly more favorable, and, also, in multivariate analysis additional treatment did not contribute significantly to the prognosis. Although thesefindingsmight suggest that additional radiotherapy or intravesical chemotherapy is ineffective, this conclusion is not justified because therapy was administered to a selected patient group, which might have had a worse prognosis without additional therapy. It is concluded that selective nuclear morphometry and DNA flow cytometry in contrast to the classic prognosticators are rather sensitive predictors of recurrent carcinoma and progressive recurrence. Because the methods result in a considerable overlapping in the determination of the cases at risk, combined application of both techniques does not improve the prognostication, except in case of failure of one of them. Practically, the findings suggest that patients presenting with a tumor with large nuclei (mean nuclear area > 95 urn 2 ) or aneuploid DNA values should be treated more aggressively. Future trials will be required to evaluate the preventive role of treatment in addition to transurethral resection of the primary tumor. References 1. Althausen AF, Prout GR Jr, Daly JJ: Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976;116: Barnes R, Hadley H, Dick A, Johnston O, Dexter J: Changes in grade and stage of recurrent bladder tumors. J Urol 1985; 118: Bjelkenkrantz K, Herder A, Grontoft O, Stal O: Cytophotometric characterization of the WHO grades of transitional cell neoplasms. Pathol Res Pract 1982;174: Blomjous CEM, Schipper NW, Baak JPA, Van Galen EM, De Voogt HJ, Meijer CJLM: Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. J Clin Pathol 1988;41: Blomjous CEM, Smeulders AWM, Vos W, Baak JPA, Van Galen EM, Meijer CJLM: A comparative study in morphometric grading of transitional cell carcinoma of the urinary bladder. Anal Quant Cytol Histol 1988 (in press). 6. Blomjous CEM, Vos W, Schipper NW, Baak JPA, De Voogt HJ, Meijer CJLM: The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma (submitted for publication). 7. Chin JL, Huben RP, Nava E, et al: Flow cytometric analysis of DNA content in human tumors and irrigation fluids. Cancer 1985;56: Collste LS, Devonec M, Darzynkiewiicz Z, et al: Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid. Cancer 198;45: Coon JS, Weinstein RS, Summers JL: Blood group precursor T- antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 1982;77: Dalesio O, Schulman CC, Sylvester R, et al: Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol 1983;129: Decenzo JM, Howard P, Irish CE: Antigenetic deletion and prognosis of patients with stage A transitional cell bladder carcinoma. J Urol 1975;114: De Sanctis PN, Tannenbaum M, Tannenbaum S, Olssen C: Morphologic quantitation of nuclear size in various grades of transitional cell carcinoma of urinary bladder. Urology 1982;2: Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD: Superficial bladder tumors (stage pta, grade 1 and 2): the importance of recurrence pattern following initial resection. J Urol 1986; 135: Fossa SD, Kalhus O, Scott-Knudsen O: The clinical and histopathological significance of Feulgen DNA values in transitional cell carcinoma of the human urinary bladder. Eur J Cancer 1977; 13: Harmer MH: TNM classification of malignant tumours. 3rd ed. Geneva: International Union against Cancer, 1978, pp Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31: Helander K, Hofer PA, Holmberg G: Karyometric investigations on urinary bladder carcinoma, correlated to histopathological grading. Virchows Arch [Pathol Anat] 1984;43: Heney NM, Nocks BN, Daly JJ, et al: Ta and Tl bladder cancer: location, recurrence and progression. Br J Urol 1982;54: Lamb D: Correlation of chromosome counts with histological appearances and prognosis in transitional cell carcinoma of bladder. Br Med J 1967;1: Lutzeyer W, Ruebben H, Dahm H: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982; 127: Melicow MM: Tumors of the urinary bladder: a clinicopathological analysis of 2,5 specimens and biopsies. J Urol 1955;74: Mostofi FK, Sobin LH, Torloni H: Histological typing of urinary bladder tumours. In: WHO, eds. International histological classification of tumours, no. 1. Geneva: World Health Organization. 1973: Ooms ECM, Kurver PHJ, Veldhuizen RW, Alons CL, Boon ME: Morphometric grading of bladder tumors in comparison with histologic grading by pathologists. Hum Pathol 1983;14: Pauli BU, Cohen SM, Alroy J, Weinstein RS: Desmosome ultrastructure and the biological behavior of chemical carcinogen induced urinary bladder carcinomas. Cancer Res 1978;38: Pauwels RPE, Smeets AWGB, Schapers RFM, Geraerdts JPM, Debruyne FMJ: Grading in superficial bladder cancer. Cytogenetic classification. Br J Urol 1988;61: Schade ROK, Swinney J: Pre-cancerous changes in bladder epithelium. Lancet 1968;2: Spooner ME, Cooper EH: Chromosome constitution of transitional cell carcinoma of the urinary bladder. Cancer 1972;29: Wiley EL, Mendelsohn G, Droller M, Eggleston JC: Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder. J Urol 1982;128: Srinivas V, Kiruluta HG: ABO(H) isoantigens in bladder tumours: a new technique of quantitative analysis. J Urol 1984;131: Tribukait B, Gustafson H, Esposti PL: The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 1 untreated cases. Br J Urol 1982;54: Wijkstroem H, Granberg-Oehlman I, Tribukait B: Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow cytofluorometric DNA study. Cancer 1984;53:

Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test

Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test 753 Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test Dr. Abhishek A Mangaonkar *, Dr. A G Valand 1 Intern, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India 2 Professor,

More information

Peritoneal Involvement in Stage II Colon Cancer

Peritoneal Involvement in Stage II Colon Cancer Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.

More information

A t recurrence, 5 15% of TaT1 urothelial cell carcinomas

A t recurrence, 5 15% of TaT1 urothelial cell carcinomas 447 ORIGINAL ARTICLE Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks M G W Bol,

More information

invasive ductal breast cancer

invasive ductal breast cancer J Clin Pathol 1987;40:1432-1436 Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer ANNE M UYTERLINDE, NELLIE W SCHIPPER, J P A

More information

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction

More information

removal and cut into slices (approximately 2 mm wax, sectioned at 4,tm, stained by Harris's and mounted in balsam.

removal and cut into slices (approximately 2 mm wax, sectioned at 4,tm, stained by Harris's and mounted in balsam. J Clin Pathol 198;35:954-958 Study of nuclear diameters in non-hodgkin's lymphomas J CROCKER, EL JONES, RC CURRAN From the Department ofpathology, The Medical School, University ofbirmingham, Edgbaston,

More information

Significance of Aneuploidy in Melanoma of the Extremity

Significance of Aneuploidy in Melanoma of the Extremity Significance of Aneuploidy in elanoma of the xtremity. W. van Oven,.D.,*. C. Baas,.D.,t J. W. Oosferhuis,.D., h.d.,* H. Schraffordf Koops,.D., h.d.,t and A. Dameiring, B.S.* 09 Tumor nuclear DNA content

More information

Bone Metastases in Muscle-Invasive Bladder Cancer

Bone Metastases in Muscle-Invasive Bladder Cancer Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer

More information

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Jpn J Clin Oncol 2002;32(11)461 465 Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Takashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, Ryoji Arata,

More information

Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer

Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer International Journal of Urology (2011) 18, 439 443 doi: 10.1111/j.1442-2042.2011.02766.x Original Article: Clinical Investigationiju_2766 439..443 Clinical significance of immediate urine cytology after

More information

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers 日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu

More information

A Review of Outcomes for Stage Ta Bladder Tumors

A Review of Outcomes for Stage Ta Bladder Tumors AJCP /ORIGINAL ARTICLE A Review of Outcomes for Stage Ta Bladder Tumors Robin T. Vollmer, MD From the VA and Duke University Medical Centers, Durham, NC. Key Words: Urothelial tumors; Tumor grade; Outcomes;

More information

Urological Oncology. Dae Hyeon Kwon, Phil Hyun Song, Hyun Tae Kim.

Urological Oncology. Dae Hyeon Kwon, Phil Hyun Song, Hyun Tae Kim. www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.7.457 Urological Oncology Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor

More information

MEDICAL POLICY SUBJECT: URINARY TUMOR MARKERS FOR BLADDER CANCER. POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: URINARY TUMOR MARKERS FOR BLADDER CANCER. POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: URINARY TUMOR MARKERS FOR PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Radical prostatectomy as radical cure of prostate cancer in a high risk group: A single-institution experience

Radical prostatectomy as radical cure of prostate cancer in a high risk group: A single-institution experience MOLECULAR AND CLINICAL ONCOLOGY 1: 337-342, 2013 Radical prostatectomy as radical cure of prostate cancer in a high risk group: A single-institution experience NOBUKI FURUBAYASHI 1, MOTONOBU NAKAMURA 1,

More information

Urological Oncology INTRODUCTION. M Hammad Ather, Masooma Zaidi

Urological Oncology INTRODUCTION. M Hammad Ather, Masooma Zaidi Urological Oncology Predicting Recurrence and Progression in Non-Muscle- Invasive Bladder Cancer Using European Organization of Research and Treatment of Cancer Risk Tables M Hammad Ather, Masooma Zaidi

More information

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis https://doi.org/10.1186/s13104-018-3319-4 BMC Research Notes RESEARCH NOTE Open Access Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis Atif Ali

More information

How Many Diseases in Carcinoma in situ?

How Many Diseases in Carcinoma in situ? How Many Diseases in Carcinoma in situ? Eva Compérat La Pitié Salpêtrière Assistance Publique Université Pierre et Marie Curie, Paris VI Carcinogenesis of Bladder Cancer (BC) BC is a panurothelial disease

More information

Radical Cystectomy Often Too Late? Yes, But...

Radical Cystectomy Often Too Late? Yes, But... european urology 50 (2006) 1129 1138 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Radical Cystectomy Often Too Late? Yes, But... Urs E. Studer

More information

Morphometric Analysis of Nuclear Features and Volume-Corrected Mitotic Index in the Prognosis of Oral Squamous Cell Carcinoma

Morphometric Analysis of Nuclear Features and Volume-Corrected Mitotic Index in the Prognosis of Oral Squamous Cell Carcinoma Oral Science International, November 2009, p.85-94 Copyright 2009, Japanese Stomatology Society. All Rights Reserved. Morphometric Analysis of Nuclear Features and Volume-Corrected Mitotic Index in the

More information

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed

More information

Comparison and Evaluation of Mitotic Figures in Oral Epithelial Dysplasia using Crystal Violet and Feulgen Stain

Comparison and Evaluation of Mitotic Figures in Oral Epithelial Dysplasia using Crystal Violet and Feulgen Stain Comparison and Evaluation of Mitotic Figures in Oral Epithelial Dysplasia using 10.5005/jp-journals-10024-1527 Crystal Violet and Feulgen Stain Original research Comparison and Evaluation of Mitotic Figures

More information

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy. 30 th Congress of the European Society of Pathology Tuesday, September 11, 2018 The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

More information

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer

More information

The diagnostic and prognostic value of genetic aberrations in resectable distal bile duct cancer Rijken, A.M.

The diagnostic and prognostic value of genetic aberrations in resectable distal bile duct cancer Rijken, A.M. UvA-DARE (Digital Academic Repository) The diagnostic and prognostic value of genetic aberrations in resectable distal bile duct cancer Rijken, A.M. Link to publication Citation for published version (APA):

More information

Controversies in the management of Non-muscle invasive bladder cancer

Controversies in the management of Non-muscle invasive bladder cancer Controversies in the management of Non-muscle invasive bladder cancer Sia Daneshmand, MD Associate Professor of Urology (Clinical Scholar) Director of Urologic Oncology Director of Clinical Research Urologic

More information

Andre W. van Zyl, Marlene B van Heerden, Emil Langenegger, Willie F.P. van Heerden

Andre W. van Zyl, Marlene B van Heerden, Emil Langenegger, Willie F.P. van Heerden Correlation between Dysplasia and Ploidy Status in Oral Leukoplakia Andre W. van Zyl, Marlene B van Heerden, Emil Langenegger, Willie F.P. van Heerden AW van Zyl, E Langenegger Department of Periodontics

More information

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,

More information

Lung cancer pleural invasion was recognized as a poor prognostic

Lung cancer pleural invasion was recognized as a poor prognostic Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD

More information

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder hashmi et al. BMC Urology (2018) 18:59 https://doi.org/10.1186/s12894-018-0373-0 RESEARCH ARTICLE Open Access Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial

More information

DNA Ploidy Analysis of Borderline Epithelial Ovarian Tumors

DNA Ploidy Analysis of Borderline Epithelial Ovarian Tumors DNA Ploidy Analysis of Borderline Epithelial Ovarian Tumors Saba Lodhi,Sabeen Najam,Shahid Pervez ( Department of Pathology, The Aga Khan University Hospital, Karachi. ) Abstract Objective: Borderline

More information

BLADDER TUMOURS A REVIEW OF 150 PATIENTS TREATED AT THE INSTITUTE OF UROLOGY AND NEPHROLOGY GENERAL HOSPITAL KUALA LUMPUR

BLADDER TUMOURS A REVIEW OF 150 PATIENTS TREATED AT THE INSTITUTE OF UROLOGY AND NEPHROLOGY GENERAL HOSPITAL KUALA LUMPUR Med. J. Malaysia Vol. 38. No. I March 1983. BLADDER TUMOURS A REVIEW OF 150 PATIENTS TREATED AT THE INSTITUTE OF UROLOGY AND NEPHROLOGY GENERAL HOSPITAL KUALA LUMPUR ZAKRIYA MAHAMOOTH HUSSAIN AWANG SUMMARY

More information

Urinary Bladder, Ureter, and Renal Pelvis

Urinary Bladder, Ureter, and Renal Pelvis Urinary Bladder, Ureter, and Renal Pelvis Protocol applies to all carcinomas of the urinary bladder, ureter, and renal pelvis. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Procedures

More information

Multiparameter Flow Cytometric Analysis of Colon Polyps

Multiparameter Flow Cytometric Analysis of Colon Polyps Multiparameter Flow Cytometric Analysis of Colon Polyps BARBARA F. BANNER, M.D., MARY S. CHACHO, M.D., DAVID L. ROSEMAN, M.D., AND JOHN S. COON, M.D., PH.D. Sixty-eight colonic polyps of various histologic

More information

ORIGINAL ARTICLE Nuclear morphometry and texture analysis on cytological smears of thyroid neoplasms: a study of 50 cases

ORIGINAL ARTICLE Nuclear morphometry and texture analysis on cytological smears of thyroid neoplasms: a study of 50 cases Malaysian J Pathol 2017; 39(1) : 33 37 ORIGINAL ARTICLE Nuclear morphometry and texture analysis on cytological smears of thyroid neoplasms: a study of 50 cases Lopamudra DEKA MD, Shilpa GUPTA MD, Ruchika

More information

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05 Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan

More information

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,

More information

Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital

Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital E-Da Medical Journal 20;():-5 Original Article Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital Wei-Ting Kuo, I-Wei Chang2, Kevin Lu, Hua-Pin Wang, Tsan-Jung u, Victor C.

More information

Collection of Recorded Radiotherapy Seminars

Collection of Recorded Radiotherapy Seminars IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology

More information

BLADDER CANCER EPIDEMIOLOGY

BLADDER CANCER EPIDEMIOLOGY BLADDER CANCER WHAT IS NEW AND CLINICALLY RELEVANT Canadian Geese - Geist Reservoir (my backyard), Indianapolis, USA BLADDER CANCER EPIDEMIOLOGY Urinary bladder 17,960 2% Urinary bladder 4,390 1.6% Siegel

More information

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney. Bladder Case Scenario 1 History 5/23/16: A 52-year-old male, smoker was admitted to our hospital with a 3-month history of right pelvic pain, multiple episodes of gross hematuria, dysuria, and extreme

More information

Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and ProgressiveTumours and Implications fortherapy

Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and ProgressiveTumours and Implications fortherapy European Urology European Urology 45 (2004) 292 296 Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and ProgressiveTumours and Implications fortherapy Barthold Ph. Schrier a, Maarten

More information

Case Presentation 58 year old male with recent history of hematuria, for which he underwent cystoscopy. A 1.5 cm papillary tumor was found in the left lateral wall of the bladder. Pictures of case Case

More information

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic

More information

Stromal Fat Content of the Parathyroid Gland

Stromal Fat Content of the Parathyroid Gland Stromal Fat Content of the Parathyroid Gland TAKAO OBARA,* YOSHIHIDE FUJIMOTO* AND MOTOHIKO AIBA** *Department of Endocrine Surgery and **Department of Surgical Pathology, Tokyo Women's Medical College,

More information

The Effects of Intravesical Chemoimmunotherapy with Gemcitabine and Bacillus Calmette Guérin in Superficial Bladder Cancer: a Preliminary Study

The Effects of Intravesical Chemoimmunotherapy with Gemcitabine and Bacillus Calmette Guérin in Superficial Bladder Cancer: a Preliminary Study The Journal of International Medical Research 2009; 37: 1823 1830 The Effects of Intravesical Chemoimmunotherapy with Gemcitabine and Bacillus Calmette Guérin in Superficial Bladder Cancer: a Preliminary

More information

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis) INTERPRETATION Dako Agilent Pathology Solutions IQFISH Interpretation Guide ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis) IT S ABOUT TIME For In Vitro Diagnostic Use ALK, ROS1,

More information

Staging and Grading Last Updated Friday, 14 November 2008

Staging and Grading Last Updated Friday, 14 November 2008 Staging and Grading Last Updated Friday, 14 November 2008 There is a staging graph below Blood in the urine is the most common indication that something is wrong. Often one will experience pain or difficulty

More information

The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis

The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis Br. J. Cancer (1990), 62, 852-856 Br. J. Cancer (1990), 62, 852-856 (~~~~~~~~~~~~~~~~~~~~~~) '." Macmillan Press Ltd., 1990 Macmillan Press Ltd., 1990~~~~~~~~~~~~~- The influence of tumour cell DNA content

More information

Rationale of The Paris System for Reporting Urinary Cytopathology: The NEW paradigm

Rationale of The Paris System for Reporting Urinary Cytopathology: The NEW paradigm Rationale of The Paris System for Reporting Urinary Cytopathology: The NEW paradigm Eva M. Wojcik, MD Professor and Chair of Pathology Professor of Urology Loyola University, Chicago, Il Why to standardize

More information

Are Prostate Carcinoma Clinical Stages T1c and T2 Similar?

Are Prostate Carcinoma Clinical Stages T1c and T2 Similar? Clinical Urology Are Clinical Stages T1c and T2 Similar? International Braz J Urol Vol. 32 (2): 165-171, March - April, 2006 Are Prostate Carcinoma Clinical Stages T1c and T2 Similar? Athanase Billis,

More information

THE CLASSIFICATION OF BLADDER TUMOURS

THE CLASSIFICATION OF BLADDER TUMOURS 41 THE CLASSIFICATION OF BLADDER TUMOURS T. J. DEELEY AND V. J. DESMET* From the Radiotherapy Department, Hammersmith Hospital, Du Cane Road, London, IF7.12, and the Department of Pathology, Louvain University,

More information

Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant

Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant Reporting Period July 1, 2012 June 30, 2013 Nonformula Grant Overview The Geisinger Clinic received $1,000,000 in nonformula funds for the

More information

Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients

Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide

More information

The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)

The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) Disclosure None Background Torino, Italy LCNC Rare tumor (2% to 3% all resected primary lung cancers) Preoperative

More information

Large Colorectal Adenomas An Approach to Pathologic Evaluation

Large Colorectal Adenomas An Approach to Pathologic Evaluation Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,

More information

Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma

Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department

More information

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 19/May 12, 2014 Page 5307

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 19/May 12, 2014 Page 5307 PROGNOSTIC SIGNIFICANCE OF PROLIFERATIVE ACTIVITY (KI67 EXPRESSION) IN OSTEOSARCOMA IN CHILDREN Moumita Paul 1, Arnab Karmakar 2, Uttara Chatterjee 3, Uttam Kumar Saha 4, Koushik Saha 5, Nanda Dulal Chatterjee

More information

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI USCAP GU Specialty Conference Case 3 March 2016 L. Priya Kunju, M.D. University of Michigan Health System Ann Arbor, MI University of Michigan Health System ACCME/Disclosures The USCAP requires that anyone

More information

A Personal History NIH CWRU U of TN U of Miami Animal Model for Bladder Cancer Carcinogen induced FANFT Three Models Primary tumors individual tumors, simulates clinical scenario of locally advanced cancer

More information

Supporting Information

Supporting Information Supporting Information Chan et al. 1.173/pnas.9654916 A Patient B Xenograft C * remaining feature of normal lymph node * * * D lymphocytes Infiltrating transitional carcinoma cells E Enlarged axillary

More information

Editorial. The Puzzle of Prostatic Carcinoma

Editorial. The Puzzle of Prostatic Carcinoma Editorial The Puzzle of Prostatic Carcinoma Carcinoma of the prostate is the most common malignant tumor in elderly men. Data from autopsy studies based on routine tissue sections indicate that the rate

More information

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer P A T H O L O G Y HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer FROM CERTAINTY COMES TRUST For in vitro diagnostic use HER2 CISH pharmdx Kit HER2 CISH pharmdx Kit is intended for dual-color

More information

Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome

Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical

More information

American Society of Cytopathology Core Curriculum in Molecular Biology

American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 6 Fluorescence in situ Hybridization (FISH) Principles

More information

Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors

Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors Romanian Journal of Morphology and Embryology 2006, 47(2):175 179 ORIGINAL PAPER Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors E. TRAŞCĂ 1), R.

More information

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy.

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy. Tumori, 96: 699-703, 2010 Influence of stage discrepancy on outcome in patients treated with radical cystectomy Ja Hyeon Ku 1, Kyung Chul Moon 2, Cheol Kwak 1, and Hyeon Hoe Kim 1 1 Department of Urology,

More information

Causes of Treatment Failure and Death in Carcinoma of the Lung

Causes of Treatment Failure and Death in Carcinoma of the Lung THE YALE JOURNAL OF BIOLOGY AND MEDICINE 54 (1981), 201-207 Causes of Treatment Failure and Death in Carcinoma of the Lung JAMES D. COX, M.D.,a AND RAYMOND A. YESNER, M.D.b The Medical College of Wisconsin,

More information

Title: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen

Title: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen Author's response to reviews Title: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen Authors: Caiyun Liu (liucaiyun23@yahoo.com.cn) Bin Dong

More information

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG At tumor board, a surgeon insists that all level II melanomas are invasive since they have broken through the

More information

Visceral pleural involvement (VPI) of lung cancer has

Visceral pleural involvement (VPI) of lung cancer has Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,

More information

Reviewing Immunotherapy for Bladder Carcinoma In Situ

Reviewing Immunotherapy for Bladder Carcinoma In Situ Reviewing Immunotherapy for Bladder Carcinoma In Situ Samir Bidnur Dept of Urologic Sciences, Grand Rounds March 1 st, 2017 Checkpoint Inhibition and Bladder Cancer, an evolving story with immunotherapy

More information

Although the international TNM classification system

Although the international TNM classification system Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru

More information

Primary Small Cell Carcinoma Of The Bladder: A Case Report And Review Of The Literature

Primary Small Cell Carcinoma Of The Bladder: A Case Report And Review Of The Literature ISPUB.COM The Internet Journal of Urology Volume 7 Number 1 Primary Small Cell Carcinoma Of The Bladder: A Case Report And Review Of The Literature T Hsieh, J Aragon-Ching, J Saia, T Sotelo Citation T

More information

Cellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases?

Cellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases? natomic Pathology / PROGNOSTIC INDICTOR FOR XILLRY LYMPH NODE METSTSES Cellular Dyscohesion in Fine-Needle spiration of reast Carcinoma Prognostic Indicator for xillary Lymph Node Metastases? nne. Schiller,

More information

Ivyspring International Publisher. Introduction. Journal of Cancer 2017, Vol. 8. Abstract

Ivyspring International Publisher. Introduction. Journal of Cancer 2017, Vol. 8. Abstract 2885 Ivyspring International Publisher Research Paper Journal of Cancer 2017; 8(15): 2885-2891. doi: 10.7150/jca.20003 Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT:

More information

Cystoscopy in children presenting with hematuria should not be overlooked

Cystoscopy in children presenting with hematuria should not be overlooked Ped Urol Case Rep 2015; 2(3):7-11 DOI: 10.14534/PUCR.2015310303 PUCR Ped Urol Case Rep PEDIATRIC UROLOGY CASE REPORTS ISSN: 2148 2969 Journal homepage: http://www.pediatricurologycasereports.com Cystoscopy

More information

Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population

Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population DOI 10.1007/s10147-015-0812-9 ORIGINAL ARTICLE Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population Yasunobu

More information

BLADDER CANCER: PATIENT INFORMATION

BLADDER CANCER: PATIENT INFORMATION BLADDER CANCER: PATIENT INFORMATION The bladder is the balloon like organ located in the pelvis that stores and empties urine. Urine is produced by the kidneys, is conducted to the bladder by the ureters,

More information

Systems Pathology in Prostate Cancer. Description

Systems Pathology in Prostate Cancer. Description Section: Medicine Effective Date: July 15, 2015 Subject: Systems Pathology in Prostate Cancer Page: 1 of 8 Last Review Status/Date: June 2015 Systems Pathology in Prostate Cancer Description Systems pathology,

More information

Upper urinary tract urothelial carcinomas (UTUC)

Upper urinary tract urothelial carcinomas (UTUC) Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract Manel Mellouli 1 *, Slim Charfi 1, Walid Smaoui 2, Rim Kallel 1, Abdelmajid Khabir 1, Mehdi Bouacida

More information

Mixed low and high grade non muscle invasive bladder cancer: a histological subtype with favorable outcome

Mixed low and high grade non muscle invasive bladder cancer: a histological subtype with favorable outcome DOI 10.1007/s00345-014-1383-5 Original Article Mixed low and high grade non muscle invasive bladder cancer: a histological subtype with favorable outcome Tina Schubert Matthew R. Danzig Srinath Kotamarti

More information

Systems Pathology in Prostate Cancer

Systems Pathology in Prostate Cancer Systems Pathology in Prostate Cancer Policy Number: 2.04.64 Last Review: 8/2014 Origination: 8/2010 Next Review: 8/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide coverage

More information

Nuclear morphometric study of Non- Hodgkin's Lymphoma (NHL)

Nuclear morphometric study of Non- Hodgkin's Lymphoma (NHL) Original Research Article Nuclear morphometric study of Non- Hodgkin's Lymphoma (NHL) Sridhar Reddy Erugula 1, P. Sujatha 2, Ayesha Sameera 3, B. Suresh Reddy 4, Jesudass Govada 5, G. Sudhakar 6, Kandukuri

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Citation for published version (APA): Cauberg, E. C. C. (2011). Advancements in diagnostic imaging for urothelial carcinoma.

Citation for published version (APA): Cauberg, E. C. C. (2011). Advancements in diagnostic imaging for urothelial carcinoma. UvA-DARE (Digital Academic Repository) Advancements in diagnostic imaging for urothelial carcinoma Cauberg, E.C.C. Link to publication Citation for published version (APA): Cauberg, E. C. C. (2011). Advancements

More information

ASSESSMENT OF GLEASON SYSTEM USE ON DIFFERENT TYPES OF PROSTATIC TISSUE SAMPLES

ASSESSMENT OF GLEASON SYSTEM USE ON DIFFERENT TYPES OF PROSTATIC TISSUE SAMPLES ASSESSMENT OF GLEASON SYSTEM USE ON DIFFERENT TYPES OF PROSTATIC TISSUE SAMPLES I. E. PLEŞEA*, B. ZAHARIA*, S. D. ENACHE**, G. MITROI***, P. TOMESCU***, O. T. POP*, P. BADEA****, A. KOŻOKIĆ***** *Department

More information

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors

More information

The clinical epidemiology of superficial bladder cancer

The clinical epidemiology of superficial bladder cancer Br. J. Cancer (1993), 67, 86-812 '." Macmillan Press Ltd., 1993 Br. J. Cancer (1993), 67, 86-812 1993 The clinical epidemiology of superficial bladder cancer L.A.L.M. Kiemeneyl2, J.A. Witjes3, A.L.M. Verbeekl2,

More information

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies

More information

Original Article. Spontaneous Healing of Breast Cancer

Original Article. Spontaneous Healing of Breast Cancer Breast Cancer Vol. 12 No. 2 April 2005 Original Article Rie Horii 1, 3, Futoshi Akiyama 1, Fujio Kasumi 2, Morio Koike 3, and Goi Sakamoto 1 1 Department of Breast Pathology, the Cancer Institute of the

More information

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei

More information

250 CASES OF CARCINOMA OF URINARY BLADDER A PRELIMINARY REVIEW

250 CASES OF CARCINOMA OF URINARY BLADDER A PRELIMINARY REVIEW 250 CASES OF CARCINOMA OF URINARY BLADDER A PRELIMINARY REVIEW Pages with reference to book, From 102 To 105 S. Adeebul Hassan Rizvi, S. Anwar Naqvi ( Department of Urology, Dow Medical College and Civil

More information

ROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW

ROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW Page564 Research Article Biological Sciences ROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW Charusheela Rajesh Gore, Chandanwale Shirish S, Ruchika Aggarwal,

More information

Pharmacologyonline 3: (2006)

Pharmacologyonline 3: (2006) INTRAVESICAL MISTLETOE EXTRACT FOR ADJUVANT TREATMENT OF SUPERFICIAL URINARY BLADDER CANCER P. Bühler 1, C. Leiber 1, M. Lucht 2, P. Wolf 1, U. Wetterauer 1, U. Elsässer-Beile 1 1 Department of Urology,

More information

HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer

HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer P A T H O L O G Y HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer For In Vitro Diagnostic Use FDA approved as an aid in the assessment of patients for whom Herceptin TM (trastuzumab) treatment

More information

NUCLEAR MORPHOMETRY IN RELATION TO METASTASES IN CANINE SPONTANEOUS CUTANEOUS SQUAMOUS CELL CARCINOMAS

NUCLEAR MORPHOMETRY IN RELATION TO METASTASES IN CANINE SPONTANEOUS CUTANEOUS SQUAMOUS CELL CARCINOMAS Trakia Journal of Sciences, Vol. 8, No. 1, pp 74-78, 2010 Copyright 2009 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7050 (print) ISSN 1313-3551 (online) Original Contribution

More information

Bladder Cancer Guidelines

Bladder Cancer Guidelines Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder

More information

Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast

Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast British Journal of Cancer (2011) 105, 698 708 All rights reserved 0007 0920/11 www.bjcancer.com Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma

More information